Author + information
- Juan F. Granada, MD⁎ ( and )
- Giora Weisz, MD
- ↵⁎Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, 8 Corporate Drive, Orangeburg, New York 10962-2614
We read with interest the letter to the editor from Drs. Kasasbeh and Zhao regarding our robotic-assisted coronary angioplasty paper (1). Their letter raises the concern that the CorPath system is not physically stationed in the room with the patient. The version used in this early clinical experience did offer an in-room configuration where the “interventional cockpit” was positioned at the foot of the x-ray table, only a few steps away from the patient. In the future, the integration of a 2-way communication feature and video function will be important options to enable the physician to use the system from a remote location in the control room as chosen by the operator.
The letter further raised the need for a safety mechanism to prevent unintentional movement of the guidewire. At the present time, the robotic system enables the physician to discretely and precisely control the guidewire and balloon/stent catheter position. While providing these controls, the system fixates the guidewire and balloon/stent catheter in place when they are not being manipulated, thus preventing any unintentional movement. In addition, the design of the system prohibits any motion of the percutaneous coronary intervention devices unless directly driven by the physician. The initial clinical experience described in this article and an ongoing clinical trial in the United States further emphasized these safety endpoints.
- American College of Cardiology Foundation